Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a potential advance in obesity treatment . Early clinical trials have demonstrated https://dillanwypn975017.tblogz.com/emerging-medication-in-australia-a-promising-solution-for-weight-loss-56971066